https://www.selleckchem.com/pr....oducts/bromopyruvic-
n early feature, evident pre-sclerosis in osteopetrosis. Following HSCT, restoration of osteoclast activity in the context of elevated bone mass produced severe and prolonged (2.5 years) hypercalcaemia. Denosumab was effective medium-term, but required concurrent long duration (11 months) zoledronic acid to manage recurrent hypercalcaemia. Fragility fractures brought appreciable additional morbidity in the post-HSCT phase.The connective tissue diseases (CTDs) demonstrating features of interstitial lung disease (ILD) include sy
Respect!
Kommentar
Delen
